Sponsor Pipeline

ORIC Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
1
Phase 3
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-23 NCT07723248 A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With… Phase 3 Recruiting
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07723248 A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With… Metastatic Castration Resistant Prostate Cancer Recruiting
Phase 1/2
NCT05315700 Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2… Solid Tumors Recruiting
Phase 1
NCT06816992 ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20… Solid Tumors Recruiting
NCT05413421 Study of ORIC-944 in Patients With Metastatic Prostate Cancer Metastatic Prostate Cancer Recruiting
Disease Areas
Prostate Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when ORIC Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free